RECRUITING

HEALTH4CLL2: a Randomized Waitlist Control Trial of Behavioral Interventions in Patients with Chronic Lymphocytic Leukemia

Conditions

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

To learn if exercise and weight management can help to improve feelings of fatigue in CLL survivors.

Official Title

HEALTH4CLL2: a Randomized Waitlist Control Trial of Behavioral Interventions in Patients with Chronic Lymphocytic Leukemia

Quick Facts

Study Start:2023-05-17

Study Completion:2025-07-03

Study Type:Not specified

Phase:Not Applicable

Enrollment:Not specified

Status:RECRUITING

Study ID

NCT05879133

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 85 Years

Sexes Eligible for Study:ALL

Accepts Healthy Volunteers:No

Standard Ages:ADULT, OLDER_ADULT

Inclusion Criteria	Exclusion Criteria
* Adults age 18-85 years of age with a histologically confirmed diagnosis of CLL and the ability to provide signed informed consent. * Self-reported physical activity will be assessed prior to enrollment and patients with a physical activity level below the level prescribed in our study will be eligible for inclusion.	* Other active malignancy within 1 year of study enrollment (excluding non-melanoma skin cancer) * Richter's transformation, another medical condition which would prevent safe participation in the behavioral intervention * Major surgery within 1 month of enrollment * Non-English speakers * Cognitively impaired adults * Pregnancy.

Contacts and Locations

Study Contact

Alessandra Ferrajoli, MD

CONTACT

(713) 792-2063

aferrajo@mdanderson.org

Principal Investigator

Alessandra Ferrajoli, MD

PRINCIPAL_INVESTIGATOR

M.D. Anderson Cancer Center

Study Locations (Sites)

M D Anderson Cancer Center

Houston, Texas, 77030

United States

Collaborators and Investigators

Sponsor: M.D. Anderson Cancer Center

Alessandra Ferrajoli, MD, PRINCIPAL_INVESTIGATOR, M.D. Anderson Cancer Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-05-17

Study Completion Date2025-07-03

Study Record Updates

Study Start Date2023-05-17

Study Completion Date2025-07-03

Terms related to this study

Additional Relevant MeSH Terms

Chronic Lymphocytic Leukemia